In this study, it was aimed to investigate the efficacy of reboxetine, a clinically prescribed drug for its antidepressant effect, on behavioral and cognitive alterations caused by diabetes in rats.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Objective: The incidence of emotional and cognitive disorders are higher in diabetic patients with respect to the general population.
📊
Key Findings & Data:Objective: The incidence of emotional and cognitive disorders are higher in diabetic patients with respect to the general population.
💡
Conclusion & Impact:In this study, it was aimed to investigate the efficacy of reboxetine, a clinically prescribed drug for its antidepressant effect, on behavioral and cognitive alterations caused by diabetes in rats.
Objective: The incidence of emotional and cognitive disorders are higher in diabetic patients with respect to the general population. In this study, it was aimed to investigate the efficacy of reboxetine, a clinically prescribed drug for its antidepressant effect, on behavioral and cognitive alterations caused by diabetes in rats.
Özet
Amaç: Diyabetik hastalarda duygu-durum hastalıklarının ve kognitif bozukluk insidansının genel popülasyona oranla daha yüksek olduğu bilinmektedir. Bu çalışmada, klinikte antidepresan etkinliği için reçete edilen reboksetin’in sıçanlarda diyabet ile indüklenen davranışsal ve bilişsel değişiklikler üzerine etkinliğinin araştırılması amaçlanmıştır.
YÜCEL, N. T., KANDEMİR, Ü., ÜÇEL, U. İ., CAN, Ö. D., ÖZKAY, Ü. D. (2023). BENEFICIAL EFFECTS OF REBOXETINE ON IMPAIRED BEHAVIORAL PARAMETERS OF DIABETIC RATS. Ankara Üniversitesi Eczacılık Fakültesi Dergisi, Cilt: 47 - Sayı: 1, 20–38. https://ajindex.com/articles/878111
American Diabetes Association (2012). Diagnosis and classification of diabetes mellitus. Diabetes Care, 35(1), 64–S71. [CrossRef] 2. Wolfsdorf, J., Glaser, N., Sperling, M.A. (2006). Diabetic ketoacidosis in infants, children, and adolescents: A consensus statement from the American Diabetes Association. Diabetes Care, 29(5), 1150–1159. [CrossRef] 3. Venkatraman, R., Singhi, S.C. (2006). Hyperglycemic hyperosmolar nonketotic syndrome. Indian Journal of Pediatrics, 73(1), 55–60. [CrossRef] 4. Tripathi, B.K., Srivastava, A.K. (2006). Diabetes mellitus: Complications and therapeutics. International Medical Journal of Experimental and Clinical Research, 12(7), 130–147. 5. Forbes, J.M., Cooper, M.E. (2013). Mechanisms of diabetic complications. Physiological Reviews, 93(1), 137–188. [CrossRef] 6. Can, O.D., Öztürk, Y. (2009). Diabetes mellitus’un diğer yüzü: Psikiyatrik ve nörodejeneratif komplikasyonlar. Turkiye Klinikleri Journal of Medical Sciences, 29(4), 968-975. 7. Kovacs, M., Goldston, D., Obrosky, D.S., Bonar, L.K. (1997). Psychiatric disorders in youths with IDDM: Rates and risk factors. Diabetes Care, 20(1), 36–44. [CrossRef] 8. Pasquier, F., Boulogne, A., Leys, D., Fontaine, P. (2006). Diabetes mellitus and dementia. Diabetes & Metabolism, 32(5), 403–414. [CrossRef] 9. Yager, J.Y. (2002). Hypoglycemic injury to the immature brain. Clinics in Perinatology, 29(4), 651-674. [CrossRef] 10. Sima, A.A., Kamiya, H., Li, Z.G. (2004).
Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. European Journal of Pharmacology, 490(1), 187–197. [CrossRef] 11. Ahmad, Q., Merali, Z. (1988). The spontaneously diabetic Wistar-BB rat manifests altered grooming and catalepsy responses: İmplications of impaired dopamine function. Progress in Neuro-Psychopharmacology & Biological Psychiatry, 12(2), 291–298. [CrossRef] 12. Hilakivi-Clarke, L.A., Wozniak, K.M., Durcan, M.J., Linnoila, M. (1990). Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression. Physiology & Behavior, 48(3), 429–433. [CrossRef] 13. Miyata, S., Hirano, S., Kamei, J. (2005). Abnormal benzodiazepine receptor function in the depressive-like behavior of diabetic mice. Pharmacology, Biochemistry, and Behavior, 82(4), 615–620. [CrossRef] 14. Kamal, A., Biessels, G.J., Duis, S.E., Gispen, W.H. (2000). Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: Interaction of diabetes and ageing. Dia